Evaluation of the colorectal cancer screening Programme in the Basque Country (Spain) and its effectiveness based on the Miscan-colon model
MetadataShow full item record
The population-based Basque Colorectal Cancer (CRC) Screening Programme started in 2009 with a biennial immunochemical quantitative test (FIT) biennial and colonoscopy under sedation in positive cases. The population target of 586,700 residents was from 50 to 69 years old and the total coverage was reached at the beginning of 2014. The aim of our study was to determine possible scenarios in terms of incidence, mortality and reduction of Life-years-Lost (L-y-L) in the medium and long term of CRC. Methods: Invitations were sent out by the Programme from 2009 to 2014, with combined organizational strategies. Simulation was done by MISCAN-colon (Microsimulation Screening Analysis) over 30 years comparing the results of screening vs no-screening, taking the population-based Cancer Registry into account. Lifetime population and real data from the Programme were used from 2008 to 2012. The model was run differentially for men and women. Results: 924,416 invitations were sent out from 2009 to 2014. The average participation rate was 68.4%, CRC detection rate was 3.4% and the Advanced Adenoma detection rate was 24.0‰, with differences observed in sex and age. Future scenarios showed a higher decrease of incidence (17.2% vs 14.7%), mortality (28.1% vs 22.4%) and L-y-L (22.6% vs 18.4%) in men than women in 2030. Conclusions: The Basque Country CRC Programme results are aligned to its strategy and comparable to other programmes. MISCAN model was found to be a useful tool to predict the benefits of the programme in the future. The effectiveness of the Programme has not been formally established as case control studies are required to determine long term benefits from the screening strategy.
Showing items related by title, author, creator and subject.
How Far Does Screening Women for Domestic (Partner) Violence in Different Health-Care Settings Meet Criteria for a Screening Programme? Systematic Reviews of Nine UK National Screening Committee CriteriaFeder, G.; Ramsay, J.; Dunne, D.; Rose, M.; Arsene, C.; Norman, Richard; Kuntze, S.; Spencer, A.; Bacchus, L.; Hague, G.; Warburton, A.; Taket, A. (2009)Objectives: The two objectives were: (1) to identify, appraise and synthesise research that is relevant toselected UK National Screening Committee (NSC) criteria for a screening programme in relation to partner violence; ...
Long-term evaluation of benefits, harms, and cost-effectiveness of the National Bowel Cancer Screening Program in Australia: a modelling studyLew, J.; St John, D.; Xu, X.; Greuter, M.; Caruana, M.; Cenin, Dayna; He, E.; Saville, M.; Grogan, P.; Coupé, V.; Canfell, K. (2017)© 2017 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license Background No assessment of the National Bowel Screening Program (NBCSP) in Australia, which considers all ...
Socio-demographic disparities in the uptake of prenatal screening and diagnosis in Western AustraliaMaxwell, Susannah; Brameld, Kate; Bower, C.; Dickinson, J.; Goldblatt, J.; Hadlow, N.; Hewitt, B.; Murch, A.; Murphy, A.; Stock, R.; O'Leary, Peter (2011)Introduction: Since the early 1980s, prenatal screening using ultrasound and biochemical markers has been used to refine the risk of Down syndrome and other fetal anomalies prior to considering fetal karyotyping. The ...